Lenar Aimee J.'s Form 4 filing
Bausch Health Companies Inc. (BHC) · filed Aug 20, 2026
- Accession no.
- 0000885590-26-000109
- Filed
- Aug 20, 2026, 4:33 PM ET
- Trade date
- Aug 19, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $258.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lenar Aimee J.CIK 0002029927 | Officer (President, US Pharma) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | Common Shares, No Par Value | SSaleDisposed | −36,827 | $7.03 | −$258,893.81 | 334,853 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.